{
  "Variants Include": [
    {
      "Gene": "PINK1",
      "variants": [
        {
          "HGVS": "(NM_001126112.3:g.309D)",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "G",
            "alt": "D",
            "position": "309"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "D",
            "position": "103"
          },
          "Description in input context": "g.309D (p.G103D)"
        },
        {
          "HGVS": "(NM_001126112.3:l.347P)",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "T",
            "alt": "P",
            "position": "347"
          },
          "Protein Change": {
            "ref": "Tyr",
            "alt": "Phe",
            "position": "115"
          },
          "Description in input context": "l.347P (p.Tyr347Phe)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Recessive parkinsonism",
    "MONDO": "MONDO:0003958"
  },
  "Experiment Method": [
    {
      "Assay Method": "In vitro kinase activity assay and immunoprecipitation followed by Western blot analysis",
      "Material used": {
        "Material Source": "Cell line and transfected mammalian cells tagged with myc or GFP",
        "Material Name": "Human diploid fibroblasts (HEK293) and transfected cells",
        "Description": "In vitro kinase activity was tested using artificial kinase-dead mutants. PINK1 localization was analyzed using immunoprecipitation followed by Western blot."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "(NM_001126112.3:g.309D)",
          "Conclusion": "Inhibition of kinase activity",
          "Molecular Effect": "complete loss-of-function",
          "Result Description": "Protein expression was abolished in G309D mutant."
        },
        {
          "Variant": "(NM_001126112.3:l.347P)",
          "Conclusion": "Significant reduction in kinase activity",
          "Molecular Effect": "reduced functionality",
          "Result Description": "Protein expression was reduced by 50% in L347P mutant."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed for each mutation type."
      },
      "Technical replicates": {
        "Technical replicates": "Two technical replicates were used for Western blot analysis."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type cDNA was used as a positive control in vitro kinase assays."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control for immunoprecipitation."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Not mentioned in the literature.",
        "Counts": "N.D"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D",
        "Counts": "N.D"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "One-way ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression ≥80%.",
        "Source": "Custom determination"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression ≤50%",
        "Source": "Custom determination"
      },
      "Approved assay": {
        "Approved assay": "Yes, Western blot is a standard method in studying kinase activity."
      }
    }
  ]
}